Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

NEOMYCIN AND POLYMY

Awarded
SPE2DP26F7736Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Logistics Agency awarded a delivery order under the IDIQ contract SPE2DX25D9900 to DMS Pharmaceutical Group Inc. (CAGE 1UNB0) for the supply of NEOMYCIN AND POLYMY, identified by NSN 6505011410827, with a total contract value of $13.18. The award was issued on July 17, 2026, under solicitation SPE2DP26F7736, and is classified as a commercial items acquisition under FAR Part 12, with firm-fixed-price terms implied by the structure and use of FAR clauses 52.212-4 and 52.212-5. Delivery is required FOB destination with a specified delivery date of August 3, 2026, to locations including FPO AE 09645-0010 and Naval Station Rota, Spain, with the Government responsible for inspection and acceptance upon arrival. The item is subject to medical substitution allowances and must comply with FDA-mandated NDC labeling, CAGE code identification, and DLAD Procurement Notes C19 and C20 for transportation and shipment. The contractor is a certified small business with multiple socioeconomic designations, including HubZone, Service-Disabled Veteran-Owned, and Women-Owned Small Business eligibility, and operates under NAICS code 424210 for wholesale pharmaceuticals. The contract incorporates FAR 52.222-50 on combating trafficking in persons and requires adherence to standard commercial item requirements without additional special clauses. Payment will be processed through the Defense Finance and Accounting Service in Columbus, Ohio, with administrative support provided by DLA Troop Support in Philadelphia; no COR or COTR is listed. The $19,999,999.00 figure referenced in the base IDIQ form is a ceiling value for the overarching contract and does not apply to this delivery order. Packaging, preservation, and barcoding requirements are implied by industry and military standards such as NDC and CAGE coding but lack explicit detail, and no specific MIL-STDs are cited. All invoicing must be submitted to the designated payment office using the Standard Form 1449, which aligns with WAWF electronic payment systems.

General Info

DMS PHARMACEUTICAL GROUP to supply NEOMYCIN AND POLYMY for $13.18 under DLA contract on July 17, 2026.

Agency

Department Of Defense → Defense Logistics AgencyView Agency

Contract Value

$13.18

NAICS

424210 - Drugs and Druggists' Sundries Merchant WholesalersView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Awardee

DMS PHARMACEUTICAL GROUP INCView Profile

Award Issued Date

Documents

(2)

SPE2DP26F7736.pdf

PDF

SPE2DP26F7736.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUS
Organization / Agency
Department Of Defense → Defense Logistics Agency
View Agency Profile
Office AddressUS
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F7736 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $13.18 Award Date: 07-17-2026 Delivery order under: SPE2DX25D9900 Line items: - NEOMYCIN AND POLYMY (NSN/Part 6505011410827, PR 7017540701)

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency